People: Dr. Reddy's Laboratories Limited (RDY)
23.39USD
9:42am EST
$-0.27 (-1.14%)
$23.66
$23.53
$23.53
$23.20
46,871
463,960
$27.33
$7.27
Vohra, Umang
Brief Biography
Mr. Umang Vohra is Chief Financial Officer of Dr. Reddy’s Laboratories Limited. He has over 13 years of experience across various functions within finance and corporate development. He is responsible for managing the company's organization’s global finance. He joined the company's in 2002, initially working as the company's Deputy Chief Financial Officer. Prior to joining the company, Mr. Vohra worked with Eicher and PepsiCo India.
Basic Compensation
| Total Annual Compensation, INR | Long-Term Incentive Plans, INR | All Other, INR | Fiscal Year Total, INR |
|---|---|---|---|
| -- | -- | -- | 5,500,000 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
| Reddy, K. Anji | 80,622 |
| Prasad, G. | 44,276 |
| Vohra, Umang | 5,500,000 |
| Mukherjee, Abhijit | 14,600,000 |
| Chakraborty, Saumen | 15,000,000 |
| Vasudevan, V. | 24,200,000 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
